Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Ovid Therapeutics, under new CEO Meg Alexander, is re‑orienting its neuroscience pipeline toward first‑in‑class KCC2 modulators while advancing a drug‑resistant epilepsy candidate toward Phase 2. The company’s earlier flagship, soticlestat, failed in Phase 3, eliminating $600 million in potential milestones, prompting a strategic shift to de‑risk R&D with biomarker programs. Recent data from OV350 demonstrated safe KCC2 activation, and the oral candidate OV4071 is slated for human trials in Parkinson’s disease psychosis this year. Ovid’s cash runway extends to 2028, giving it time to prove the KCC2 approach across multiple CNS indications.
$CMPS first-in-line for potential psychedelic approval for Treatment Resistant Depression (TRD) . Likely war between "Old School FDA" and MAHA movement. Will be exciting to see the outcome. $HELP with strong data for Major Depressive Disorder (MDD) and Breakthrough Therapy Designation. New...
Vertex Pharmaceuticals reported that its late‑stage RAINIER trial of povetacicept in IgA nephropathy is proceeding without safety concerns, with primary data expected in the first half of 2026. The company is leveraging a priority‑review voucher for the upcoming FDA filing...
Organotics, a new biotech startup, is leveraging patient‑derived brain organoids to accelerate early‑stage testing of neuropsychiatric drugs. By reprogramming a patient’s blood or skin cells into induced pluripotent stem cells, the company creates vascularized, multi‑region mini‑brains that reflect individual genetics....
India‑based health‑AI startup Krigat captured the Supernova AI MEA Champion title in Cairo, outpacing 74 finalists from over 30 countries. The win includes a $10,000 equity‑free cash prize and heightened visibility at the AI Everything MEA summit. Krigat’s platform leverages...
Jason Wilt, an emergency and sports‑medicine physician, recounts his stint at Williams‑Sonoma and how the harsh retail environment taught him to handle difficult patients. He draws parallels between customer aggression and patient hostility, noting that many patients’ frustration stems from...
Paul Hudson has struggled to revitalize Sanofi’s R&D engine despite a series of high‑profile acquisitions since becoming CEO in 2019. The French group’s pipeline has underperformed, and recent buyouts have failed to deliver the expected boost in innovative drug candidates....
The episode dissects OpenClaw, an open‑source, agentic AI platform that can autonomously interact with files, commands, and dozens of applications, and evaluates its viability for payer and provider health organizations. It explains why the default, unsecured version violates HIPAA, outlines...
PTC Therapeutics has withdrawn its FDA filing for Translarna (ataluren) as a treatment for nonsense‑mutation Duchenne muscular dystrophy after the agency indicated the data would not meet the threshold for substantial evidence of effectiveness. The decision ends a decade‑long effort...
Medicare Part B lab spending reached $8.4 billion in 2024, up 5 % year‑over‑year. Genetic tests, though only 5 % of test volume, accounted for 43 % of the dollar value, driving a $3.6 billion surge. Utilization of molecular diagnostics jumped 160 % since 2018, while routine...
Novo Nordisk has filed a patent lawsuit against telehealth firm Hims & Hers, alleging illegal compounding of semaglutide after the FDA declared the drug no longer in shortage. The case targets the surge in compounded Wegovy and Ozempic that emerged...
KFF Health News published a Valentine‑themed roundup of reader‑submitted poems and cartoons that lampoon current health‑policy woes. Submissions spotlight upcoding scandals, soaring insurance premiums, the rise of AI‑driven telehealth, and gaps in menopause expertise. The piece blends humor with genuine...
The Centers for Medicare & Medicaid Services abruptly terminated the Making Care Primary initiative, a ten‑year federal program designed to bolster primary care in rural areas, after just one year of operation. The model had enrolled roughly 700 practices across...
Philips has launched the InkSpace Imaging Snuggle, a flexible paediatric body array coil for its 3.0 T MRI platforms. The blanket‑like, lightweight design wraps around children, aiming to reduce anxiety and improve comfort. Its high‑density array delivers sharp, high‑resolution images, cutting...
Lyell Immunopharma has administered the first dose of its investigational CAR‑T therapy, ronde‑cel (LYL314), in the Phase III PiNACLE‑H2H trial for relapsed or refractory large B‑cell lymphoma. The head‑to‑head study randomizes roughly 400 patients to receive either ronde‑cel at 100 × 10⁶ cells...
The UK government announced a 3.3% pay rise for roughly 1.5 million NHS nurses, midwives and allied health staff in England and Wales, effective 2026‑27. The increase outpaces the Office for Budget Responsibility's 2.2% inflation forecast but falls short of the...
ProPhet, an Israeli AI‑driven startup founded in late 2024, leverages a novel machine‑learning platform that projects proteins and small molecules into a common interaction space. This approach allows the company to screen billions of compounds against targets previously deemed undruggable,...
The U.S. FDA declined to review Moderna's mRNA influenza vaccine, even though two phase‑3 trials involving 43,800 participants demonstrated a 27% efficacy advantage over the standard Fluarix vaccine and a 49% reduction in hospitalizations. FDA officials cited the comparator arm...
Novocure received FDA clearance for its Optune Pax tumor‑treating‑field device in locally advanced pancreatic cancer, marking the company’s first indication beyond brain tumors. The pivotal trial of 571 patients showed a statistically significant two‑month overall‑survival gain (16.2 vs 14.2 months) when the device was...
Biometric authentication is now mainstream in U.S. healthcare, with roughly 78% of organizations deploying fingerprint or facial‑recognition systems. The technology promises stronger identity assurance, faster workflow access, and reduced patient misidentification, directly addressing HIPAA compliance and safety concerns. However, high...
Healthcare payers are increasingly judged on billing accuracy and financial predictability, making data integrity a strategic priority. Clean, verified data enables faster eligibility checks, claim approvals, and reduces manual interventions, directly improving operational efficiency. By minimizing billing errors, payers lower...
Medicomp Systems unveiled a Model Context Protocol (MCP) that links generative AI models to its 45‑year clinical knowledge graph, filtering hallucinations before data enters electronic health records. The suite enables safe AI APIs for diagnostic prompting, chart summarization, quality‑measure evaluation,...
The episode explores the rapid convergence of organoid technology and artificial intelligence, highlighting how AI-driven image analysis, multidimensional data integration, and high‑throughput screening are transforming organoid research. It introduces the emerging field of Organoid Intelligence, where brain organoids act as...
Specialized mobility restoration providers are increasingly judged on multidisciplinary expertise, advanced prosthetic technology, and measurable outcomes. The article outlines key components such as individualized assessments, integrated rehab services, and continuous patient education that signal high‑quality care. It also highlights the...
Insights from Mark Molinaro, founder and CEO of SkySpigot
The University of South Florida installs Allia Moveo image-guided therapy system
Snuggle body array coil from InkSpace Imaging was recently FDA cleared
British Airways cabin crew members were hospitalized after unknowingly consuming cannabis‑infused gummies presented by a passenger following a London‑Los Angeles flight. The edibles contained a high 300 mg dose of THC, causing panic, disorientation and intense anxiety before the crew recovered...
Encompass Health and its spin‑off Enhabit have secured a $43.1 million award in attorneys’ fees and mitigation damages from VitalCaring. A Delaware federal judge ordered that 43% of VitalCaring’s future profits and any exit proceeds be placed in trust and split...
Northwestern researchers engineered a spherical nucleic acid (SNA) vaccine in which the HPV16 E7 peptide is displayed at the nanoparticle surface via its N‑terminus. This N‑terminal orientation (N‑HSNA) generated up to eight‑fold higher interferon‑γ secretion and 2.5‑fold greater cytotoxicity than...
Iliad Biotechnologies announced a $115 million Series B round, the largest venture deal of the week, led by RA Capital Management. New investors Janus Henderson and BNP Paribas Asset Management Alts also participated. The funding will accelerate Iliad’s intranasal vaccine program targeting pertussis...
For the Nancy Guthrie case, an idea and maybe a crazy one but she had a pacemaker which often implantable devices use bluetooth such as Medtronic's. Couldn't you war-drive (drones even better) with a high gain antenna with amplifiers -...
The American Academy of Pediatrics has become a leader in the effort to reverse RFK Jr.'s vaccine policies. The success — or failure — of the group's approach will have consequences for kids' health nationwide. Inside the AAP's plan for the MAHA...
The U.S. Department of Health and Human Services has issued a December proposed rule to overhaul the Transparency in Coverage (TiC) machine‑readable files, with implementation slated for 2027. The rule would filter out payment rates that never apply to a...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) is stripping references to "biodefense" and "pandemic preparedness" from its website and will de‑prioritise related research. About a third of its $6.6 billion budget, roughly $2.2 billion, currently funds emerging‑pathogen and biodefense...
Seven Democratic senators reintroduced the Nurses Belong in Nursing Homes Act to restore federal staffing standards that were struck down by courts. The bill would require a registered nurse on site 24/7 and a minimum of 3.5 care hours per...
On Feb 12, HHS announced that health insurers covering roughly 165 million Americans have pledged to implement digital‑health reimbursement models modeled on CMS’s ACCESS program by Jan 1 2028. The ACCESS model adjusts payments based on measurable patient‑outcome impact, shifting from volume‑based to value‑based...
A multi‑drug‑resistant tuberculosis (MDR‑TB) ward in northern Cameroon continues to confine patients like Asta Djouma for months, despite World Health Organization guidelines that deem long‑term isolation obsolete. The government mandates hospitalization until patients test negative, separating them from families and...
The Centers for Disease Control and Prevention and the National Institutes of Health announced a new performance‑review framework that links lower ratings to easier termination. The policy reclassifies a swath of federal staff into a category with reduced civil‑service protections,...
The EPCORE NHL‑1 trial released three‑year data showing that epcoritamab (Epkinly) delivers deep, durable remissions in heavily pre‑treated large B‑cell lymphoma. Among patients who achieved a complete response, 53% remained progression‑free at the data cutoff, with a median CR duration...
A recent Chinese study finds surgery slightly more cost‑effective than radiotherapy for esophageal squamous cell carcinoma (ESCC). Using a TreeAge Pro Markov model on 196 real‑world patients, surgery delivered longer median overall survival (41.3 vs 30.4 months) and higher quality‑adjusted life...
The Identity Theft Resource Center’s 2025 Data Breach Report reveals a 79 % surge in U.S. data compromises, with 534 incidents targeting health‑care providers. Private‑practice physicians face precise, AI‑driven attacks that exploit patient records and vendor relationships. Transparency in breach notifications...
For my book Allergic, I went to Cincinnati Children's Hospital and talked to asthma experts that vehemently argued otherwise...with decades of data behind them. Young (and old) lungs especially need the cleanest air we can manage. This is one of the...
Earnings roundup: Neurocrine slumps, Alnylam battles skeptics and Ascendis eyes a competitor https://t.co/kU1ex80A24 by @realJacobBell $NBIX - 10% $ALNY - 4% $ASND - 2% $BBIO #biotech
The phase III LAIS trial showed that loberamisal, a novel neuroprotectant, raised the proportion of acute ischemic‑stroke patients achieving an excellent functional outcome (mRS 0‑1) to 69.7% versus 56.4% with placebo when given within 48 hours of symptom onset. The study enrolled 997...
#TEFCA, America’s National Interoperability Network, Reaches Nearly 500 Million Health Records Exchanged as @HHSGov + @HHS_TechPolicy Leverages #Technology and #AI to Lower Costs and Reduce Burden #ASTP2026 https://t.co/0iBnnjnNR3 https://t.co/oFI2brZmfq
A bipartisan group of 100 lawmakers, led by Reps. Yvette Clarke and Michael Lawler, sent a letter to the Department of Homeland Security urging an exemption from the $100,000 H‑1B filing fee for health‑care workers. The request is backed by...
The Administration for Strategic Preparedness and Response (ASPR) has unveiled a $100 million Small Molecule Approaches for Rapid and Robust Treatment Prize to spur antiviral drug development. The competition targets viruses in the Togaviridae and Flaviviridae families, including dengue, Zika, West...
Kainova Therapeutics announced a CAD 32 million first close of its Series B financing, led by Investissement Québec and supported by existing backers. The funding brings total venture capital to about $90 million USD and will accelerate development of its GPCR‑focused drug candidates. Lead...
